Viable and high-throughput isolation of heterogeneous circulating tumor cells using tapered-slit filters

Abstract Circulating tumor cells (CTCs) have received a great amount of attention, as they are known to promote metastatic spread of cancer. Despite a wide variety of techniques developed to utilize CTCs as a diagnostic and prognostic tumor biomarker, clinical trials based on CTC analysis have shown inconsistent benefits due to difficulties in isolating these heterogeneous rare cells with high sensitivity, as well as maintaining their viability. Here, we developed a tapered slit filter (TSF) for high throughput isolation of viable heterogeneous CTCs. TSF prototypes were fabricated using a single-mask photolithography of SU-8 dry films, which were achieved by precisely adjusting UV exposure condition. The numerical analysis and in vitro cell capture assay revealed that the optimal TSF prototype was capable to reduce the stress applied on cells by 10 % compared to straight-walled slit filters (SSFs), which in turns enabled high throughput (25 mL/h), viable (87–94 %), and highly sensitive (83–100 %) capture of cancer cells, regardless of their epithelial/mesenchymal features. As a result, TSF outperformed conventional CTC isolation devices (or methods), as an EpCAM-targeting approach demonstrated low capture efficiency for mesenchymal-like SW620 cells (∼10 %), while sharp edges of the SSFs significantly reduced the cell viability (∼70 %). The clinical study using blood samples obtained from colorectal cancer patients further demonstrated that TSF was capable to isolate heterogeneous CTC subtypes, which expressed epithelial, mesenchymal, or hybrid of epithelial/mesenchymal markers. The results presented in this study support that the new device has potential to provide in-depth information on pathological status of the patients.

[1]  R. Matkowski,et al.  Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score. , 2014, Anticancer research.

[2]  D. Planchard,et al.  A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas , 2011, British Journal of Cancer.

[3]  Klaus Pantel,et al.  Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.

[4]  Young-Ho Cho,et al.  Polyester fabric sheet layers functionalized with graphene oxide for sensitive isolation of circulating tumor cells. , 2017, Biomaterials.

[5]  Bo Lu,et al.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.

[6]  Y. Dong,et al.  Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer , 2016, Oncotarget.

[7]  S. Hanash,et al.  Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas , 2019, Pharmacology & therapeutics.

[8]  F. Nicolantonio,et al.  Liquid biopsy: monitoring cancer-genetics in the blood , 2013, Nature Reviews Clinical Oncology.

[9]  M. Sanz-Casla,et al.  Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Warren,et al.  Challenges and opportunities in measuring cancer recurrence in the United States. , 2015, Journal of the National Cancer Institute.

[11]  M. Tang,et al.  Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation , 2015, Oncotarget.

[12]  Andrew J Armstrong,et al.  Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .

[13]  X. Guan,et al.  Cancer metastases: challenges and opportunities , 2015, Acta pharmaceutica Sinica. B.

[14]  Sae-Won Han,et al.  Enhancement of isolation sensitivity for the viable heterogeneous circulating tumor cells swelled by hypo-osmotic pressure , 2017 .

[15]  Jaap M. J. den Toonder,et al.  Circulating tumor cells: the Grand Challenge. , 2011, Lab on a chip.

[16]  M. Páez de la Cadena,et al.  Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets , 2019, Biology Open.

[17]  Gang Li,et al.  A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells. , 2015, Biosensors & bioelectronics.

[18]  Taisuke Masuda,et al.  Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis , 2014, PloS one.

[19]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[20]  Filippos Koinis,et al.  Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy , 2014, Breast Cancer Research.

[21]  Jongyoon Han,et al.  Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics , 2015, Nature Protocols.

[22]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[23]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Sung-Bum Kang,et al.  A viable circulating tumor cell isolation device with high retrieval efficiency using a reversibly deformable membrane barrier , 2017 .

[25]  M. Rostami,et al.  Atomic force microscope-based single cell force spectroscopy of breast cancer cell lines: an approach for evaluating cellular invasion. , 2014, Journal of biomechanics.

[26]  P. Jänne,et al.  A new device for rapid isolation by size and characterization of rare circulating tumor cells. , 2011, Anticancer research.

[27]  Renjun Pei,et al.  High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method. , 2018, Biosensors & bioelectronics.

[28]  I. Tinhofer,et al.  Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.

[29]  S. Miyano,et al.  Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. , 2013, Cancer research.

[30]  M. Garg Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis , 2017, Expert Reviews in Molecular Medicine.

[31]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Andrew Z. Wang,et al.  Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application. , 2020, Biosensors & bioelectronics.

[33]  S. Groshen,et al.  Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.

[34]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[35]  Young-Ho Cho,et al.  Lab on a fabric: Mass producible and low-cost fabric filters for the high-throughput viable isolation of circulating tumor cells. , 2017, Biosensors & bioelectronics.

[36]  Nallasivam Palanisamy,et al.  High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients , 2020, Cancers.

[37]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[38]  J. Inazawa,et al.  SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation , 2012, Oncogene.

[39]  D. Haber,et al.  Microfluidic isolation of platelet-covered circulating tumor cells. , 2017, Lab on a chip.